[HTML][HTML] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - ESMO open, 2021 - Elsevier
Introduction The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - ESMO Open, 2021 - europepmc.org
Methods This retrospective single-institution analysis compared the clinical pathological
characteristics of BC diagnosed between May 2020 and July 2020, after a 2-month …
characteristics of BC diagnosed between May 2020 and July 2020, after a 2-month …
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - ESMO OPEN, 2021 - iris.unimore.it
The present analysis aims to evaluate the consequences of a 2-month interruption of
mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments …
mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments …
[PDF][PDF] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - scholar.archive.org
Introduction: The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
[HTML][HTML] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - ESMO Open, 2021 - ncbi.nlm.nih.gov
Methods This retrospective single-institution analysis compared the clinical pathological
characteristics of BC diagnosed between May 2020 and July 2020, after a 2-month …
characteristics of BC diagnosed between May 2020 and July 2020, after a 2-month …
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso… - ESMO …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
[PDF][PDF] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - angelaserra.com
Introduction: The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
[HTML][HTML] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - ESMO Open, 2021 - esmoopen.com
Introduction The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
[PDF][PDF] Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
A Toss, C Isca, M Venturelli, C Nasso, G Ficarra… - iris.unimore.it
Introduction: The present analysis aims to evaluate the consequences of a 2-month
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …
interruption of mammographic screening on breast cancer (BC) stage at diagnosis and …